Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial - The Lancet
Dr. Sheila Sahni on X: "Algorithm for switching between oral P2Y12 inhibitors in the acute and chronic setting. (For the Figure: LD = loading dose; MD = maintenance dose) Source: 2017 ESC
![PDF] De-escalation therapy after acute coronary syndrome: is it reasonable to switch from prasugrel (or ticagrelor) to clopidogrel early? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9821495c3b180b474079b1b8e98cc52218703a27/4-Figure1-1.png "PDF] De-escalation therapy after acute coronary syndrome: is it reasonable to switch from prasugrel (or ticagrelor) to clopidogrel early? | Semantic Scholar")
PDF] De-escalation therapy after acute coronary syndrome: is it reasonable to switch from prasugrel (or ticagrelor) to clopidogrel early? | Semantic Scholar
How to Switch from Clopidogrel to Prasugrel or Ticagrelor - ppt download
Dual Antiplatelet and Glycoprotein Inhibitors in Emergency PCI | SpringerLink
JCM | Free Full-Text | Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina
Effectiveness and Safety of Ticagrelor Implementation in Patients with Acute Coronary Syndrome undergoing Percutaneous Coronary Intervention: A Cohort Study in Western Denmark - The Lancet Regional Health – Europe
Should You Switch the DAPT Agent a Month After ACS? | Clinician Reviews
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors Oral ... | GrepMed
Switching mode between the P2Y 12 platelet receptor inhibitors, acute... | Download Scientific Diagram
CHANGE DAPT: Study Contests Benefit of Ticagrelor Over Clopidogrel After PCI in ACS | tctmd.com
Journal of Invasive Cardiology - An acute antiplatelet-switching strategy: Using prasugrel or ticagrelor for rapid and reliable periprocedural antiplatelet action, followed by a switch to clopidogrel -- The SWITCH Study Antoine E.
Frontiers | Prevalence of adverse events during ticagrelor versus clopidogrel treatment and its association with premature discontinuation of dual antiplatelet therapy in East Asian patients with acute coronary syndrome
Switching to and from Cangrelor: When and How?
International Expert Consensus on Switching Platelet P2Y<sub>12</sub> Receptorâ•fiInhibiting Therapies
Pharmacodynamic profiles of switching from ticagrelor to clopidogrel... | Download Scientific Diagram
Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI: SWAP-4 | tctmd.com
Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial | The BMJ
2020 APSC Recommendations on use of P2Y12 inhibitors in Asia
Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease | Circulation
Switching P2Y12-receptor inhibitors in patients with coronary artery disease | Nature Reviews Cardiology
Cardiac Diseases and Therapies ACUTE CORONARY SYNDROMES ANTIPLATELET THERAPY SWITCHING CLINICIAN GUIDE
JCM | Free Full-Text | Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina
Therapeutic Window of Clopidogrel and Ticagrelor in Patients With Critical Limb-Threatening Ischemia - Ashwat S. Dhillon, Jorge Caro, Han Tun, David G. Armstrong, Vincent Rowe, David M. Shavelle, Leonardo C. Clavijo, 2020
Newsletter December 2018
